Free Trial

Regulus Therapeutics (RGLS) Short Interest Ratio & Short Volume

Regulus Therapeutics logo
$1.53 -0.06 (-3.77%)
(As of 05:45 PM ET)

Regulus Therapeutics Short Interest Data

Regulus Therapeutics (RGLS) has a short interest of 1.40 million shares, representing 2.65% of the float (the number of shares available for trading by the public). This marks a -14.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.0, indicating that it would take 4.0 days of the average trading volume of 1.15 million shares to cover all short positions.

Current Short Interest
1,400,000 shares
Previous Short Interest
1,640,000 shares
Change Vs. Previous Month
-14.63%
Dollar Volume Sold Short
$2.25 million
Short Interest Ratio
4.0 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
65,500,000 shares
Float Size
52,920,000 shares
Short Percent of Float
2.65%
Today's Trading Volume
309,858 shares
Average Trading Volume
1,151,269 shares
Today's Volume Vs. Average
27%
Short Selling Regulus Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Regulus Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RGLS Short Interest Over Time

RGLS Days to Cover Over Time

RGLS Percentage of Float Shorted Over Time

Regulus Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/20241,400,000 shares $2.25 million -14.6%2.7%4 $1.61
11/15/20241,640,000 shares $2.35 million -3.0%3.1%4.6 $1.43
10/31/20241,690,000 shares $2.47 million -32.4%3.2%4.7 $1.46
10/15/20242,500,000 shares $3.75 million -12.3%4.7%7.3 $1.50
9/30/20242,850,000 shares $4.47 million -13.4%5.4%7.7 $1.57
9/15/20243,290,000 shares $5.30 million -1.2%6.2%4.6 $1.61
8/31/20243,330,000 shares $5.59 million -7.0%6.3%4.2 $1.68
8/15/20243,580,000 shares $5.69 million -8.7%6.8%4.4 $1.59
7/31/20243,920,000 shares $7.06 million -9.7%7.4%4.6 $1.80
7/15/20244,340,000 shares $7.55 million -18.1%8.2%5.3 $1.74
6/30/20245,300,000 shares $9.46 million +48.0%10.0%6.6 $1.79
6/15/20243,580,000 shares $8.63 million +38.2%6.8%5.1 $2.41
5/31/20242,590,000 shares $5.93 million -10.1%4.9%0.8 $2.29
5/15/20242,880,000 shares $5.82 million -31.6%5.4%0.9 $2.02
4/30/20244,210,000 shares $9.68 million -32.9%7.3%1.4 $2.30
4/15/20246,270,000 shares $17.43 million +15.7%10.9%2.1 $2.78
3/31/20245,420,000 shares $15.61 million +5.7%9.4%1.8 $2.88
3/15/20245,130,000 shares $10.82 million +9,244.3%13.0%1.8 $2.11
2/29/202454,900 shares $80,703.00 -43.4%0.3%1.4 $1.47
2/15/202497,000 shares $143,560.00 -16.6%0.6%2.6 $1.48
1/31/2024116,300 shares $147,701.00 -7.3%0.7%4.4 $1.27
1/15/2024125,500 shares $163,150.00 -9.3%0.7%5.1 $1.30
12/31/2023138,400 shares $177,152.00 -6.6%0.8%6.9 $1.28
12/15/2023148,100 shares $202,897.00 -0.1%0.9%7.6 $1.37
11/30/2023148,200 shares $194,142.00 -18.3%0.9%4.4 $1.31
11/15/2023181,300 shares $252,007.00 -5.2%1.0%4.9 $1.39
10/31/2023191,200 shares $231,352.00 -0.7%1.1%5.4 $1.21
10/15/2023192,600 shares $242,676.00 -1.0%1.2%5.5 $1.26
9/30/2023194,500 shares $266,465.00 -0.2%1.2%5.6 $1.37
9/15/2023194,800 shares $331,160.00 +4.2%1.2%5.6 $1.70
8/31/2023187,000 shares $291,720.00 -10.2%1.1%5.7 $1.56
8/15/2023208,300 shares $281,205.00 -3.7%1.3%9.6 $1.35
7/31/2023216,300 shares $302,820.00 -3.9%1.3%7.8 $1.40
7/15/2023225,000 shares $328,500.00 -2.5%1.4%7.7 $1.46
6/30/2023230,700 shares $339,129.00 +6.5%1.4%4.1 $1.47
6/15/2023216,700 shares $312,048.00 +3.0%1.3%3.4 $1.44
5/31/2023210,300 shares $273,390.00 -17.1%1.3%3.1 $1.30
5/15/2023253,700 shares $393,235.00 +26.0%1.6%3.8 $1.55
4/30/2023201,300 shares $268,735.50 +18.1%1.4%3.4 $1.34
4/15/2023170,500 shares $202,895.00 -13.9%1.2%2.6 $1.19
No one’s talking about these Trump trades (Ad)

As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today
3/31/2023198,000 shares $167,805.00 +11.1%1.3%4.8 $0.85
3/15/2023178,200 shares $215,622.00 -3.7%1.2%4 $1.21
2/28/2023185,100 shares $248,034.00 -1.9%1.3%4.1 $1.34
2/15/2023188,600 shares $262,154.00 -6.8%1.3%4.2 $1.39
1/31/2023202,400 shares $291,456.00 -3.2%1.4%4.3 $1.44
1/15/2023209,000 shares $311,410.00 +0.8%1.4%4.7 $1.49
12/30/2022207,400 shares $284,138.00 -10.8%1.4%4.7 $1.37
12/15/2022232,600 shares $327,966.00 -16.2%1.6%5.4 $1.41
11/30/2022277,500 shares $474,525.00 -2.6%1.9%0.3 $1.71
11/15/2022284,900 shares $490,028.00 +5.1%2.0%0.3 $1.72
10/31/2022271,100 shares $420,205.00 -1.7%N/A0.3 $1.55
10/15/2022275,900 shares $449,717.00 -7.4%N/A0.3 $1.63
9/30/2022297,900 shares $506,430.00 -49.9%N/A0.3 $1.70
9/15/2022594,600 shares $1.24 million +98.7%N/A0.7 $2.09
8/31/2022299,300 shares $425,006.00 -15.2%N/A0.4 $1.42
8/15/2022353,000 shares $638,930.00 +56.1%N/A3 $1.81
7/31/2022226,200 shares $364,182.00 -7.1%N/A1 $1.61
7/15/2022243,500 shares $560,050.00 +1.4%N/A1.2 $2.30
6/30/2022240,100 shares $497,007.00 -91.3%N/A1.2 $2.07
6/15/20222,770,000 shares $678,927.00 -9.2%N/A1.4 $0.25
5/31/20223,050,000 shares $873,825.00 -30.8%N/A1.5 $0.29
5/15/20224,410,000 shares $948,150.00 +53.1%N/A2 $0.22
4/30/20222,880,000 shares $581,760.00 -10.8%N/A2.7 $0.20
4/15/20223,230,000 shares $823,650.00 -2.4%N/A2.8 $0.26
3/31/20223,310,000 shares $986,380.00 +1.5%N/A2.3 $0.30
3/15/20223,260,000 shares $867,160.00 +21.2%N/A2.3 $0.27
2/28/20222,690,000 shares $605,250.00 -17.5%N/A1.9 $0.23
2/15/20223,260,000 shares $815,326.00 +4.5%N/A2.5 $0.25
1/31/20223,120,000 shares $769,704.00 +24.8%4.2%2.2 $0.25
1/15/20222,500,000 shares $617,500.00 -8.8%3.3%1.5 $0.25
12/31/20212,740,000 shares $863,100.00 -18.7%4.1%1.3 $0.32
12/15/20213,370,000 shares $1.18 million -0.6%5.1%1.6 $0.35
11/30/20213,390,000 shares $1.31 million -19.7%4.5%1.7 $0.39
11/15/20214,220,000 shares $1.76 million -4.5%N/A2.1 $0.42
10/29/20214,420,000 shares $2.04 million -8.3%N/A2.3 $0.46
10/15/20214,820,000 shares $2.34 million -8.5%N/A2.9 $0.49
9/30/20215,270,000 shares $3.64 million +6.0%N/A6.5 $0.69
9/15/20214,970,000 shares $3.48 million +0.4%N/A4 $0.70
8/31/20214,950,000 shares $3.84 million -5.9%N/A1.7 $0.78
8/13/20215,260,000 shares $3.53 million -0.8%N/A1.7 $0.67
7/30/20215,300,000 shares $3.71 million -12.3%8.2%1.7 $0.70
7/15/20216,040,000 shares $4.35 million -2.6%9.3%1.9 $0.72
6/30/20216,200,000 shares $5.04 million +4.7%9.6%1.9 $0.81
6/15/20215,920,000 shares $5.52 million +0.2%9.1%2 $0.93
5/28/20215,910,000 shares $5.83 million No Change9.1%1.6 $0.99
5/14/20215,910,000 shares $4.85 million -5.4%N/A2.1 $0.82
4/30/20216,250,000 shares $9.19 million -3.0%N/A2.1 $1.47
4/15/20216,440,000 shares $8.76 million -3.5%N/A2 $1.36
3/31/20216,670,000 shares $10.41 million +31.3%N/A2.1 $1.56
3/15/20215,080,000 shares $9.96 million +61.8%N/A1.5 $1.96
No one’s talking about these Trump trades (Ad)

As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today
2/26/20213,140,000 shares $4.11 million +13.8%N/A1.2 $1.31
2/12/20212,760,000 shares $4.50 million +16.0%N/A1.1 $1.63
1/29/20212,380,000 shares $3.33 million +31.5%N/A1.1 $1.40
1/15/20211,810,000 shares $2.15 million +24.0%N/A0.9 $1.19
12/31/20201,460,000 shares $1.88 million +35.2%N/A0.9 $1.29
12/15/20201,080,000 shares $1.24 million +54.8%N/A0.7 $1.15
11/30/2020697,800 shares $444,289.26 -30.0%N/A0.9 $0.64
11/15/2020997,100 shares $518,492.00 +7.0%N/A2.1 $0.52
10/30/2020932,300 shares $444,520.64 +12.9%N/A1.8 $0.48
10/15/2020826,100 shares $450,637.55 -6.8%N/A0.6 $0.55
9/30/2020885,900 shares $455,352.60 -19.5%N/A0.5 $0.51
9/15/20201,100,000 shares $611,600.00 -4.4%N/A0.5 $0.56
8/31/20201,150,000 shares $609,500.00 -27.7%N/A0.4 $0.53
8/14/20201,590,000 shares $969,900.00 -3.6%N/A0.6 $0.61
7/31/20201,650,000 shares $1.16 million +131.2%N/A0.6 $0.70
7/15/2020713,800 shares $548,269.78 +189.8%N/A0.4 $0.77
6/30/2020246,300 shares $176,104.50 -65.8%N/A0.2 $0.72
6/15/2020720,200 shares $677,060.02 +25.6%N/A0.6 $0.94
5/29/2020573,600 shares $430,200.00 -15.9%N/A1 $0.75
5/15/2020681,900 shares $408,458.10 +17.9%N/A2.1 $0.60
4/30/2020578,500 shares $296,770.50 +3.9%N/A2.1 $0.51
4/15/2020556,600 shares $263,438.78 +2.8%3.5%2.7 $0.47
3/31/2020541,500 shares $254,505.00 -2.7%3.4%3 $0.47
3/13/2020556,700 shares $250,515.00 -0.3%3.5%4.7 $0.45
2/28/2020558,200 shares $245,608.00 -1.1%3.5%1.9 $0.44
2/14/2020564,100 shares $383,588.00 -16.5%3.5%1.9 $0.68
1/31/2020675,300 shares $492,969.00 +3.1%4.2%2.4 $0.73
1/15/2020654,800 shares $628,608.00 +35.8%3.8%2.4 $0.96
12/31/2019482,200 shares $564,174.00 +59.1%2.8%1.9 $1.17

RGLS Short Interest - Frequently Asked Questions

What is Regulus Therapeutics' current short interest?

Short interest is the volume of Regulus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 1,400,000 shares of RGLS short. 2.65% of Regulus Therapeutics' shares are currently sold short. Learn More on Regulus Therapeutics' current short interest.

What is a good short interest ratio for Regulus Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGLS shares currently have a short interest ratio of 4.0. Learn More on Regulus Therapeutics's short interest ratio.

What is a good short interest percentage for Regulus Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.65% of Regulus Therapeutics' floating shares are currently sold short.

Is Regulus Therapeutics' short interest increasing or decreasing?

Regulus Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 1,400,000 shares, a decline of 14.6% from the previous total of 1,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Regulus Therapeutics' float size?

Regulus Therapeutics currently has issued a total of 65,500,000 shares. Some of Regulus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regulus Therapeutics currently has a public float of 52,920,000 shares.

How does Regulus Therapeutics' short interest compare to its competitors?

2.65% of Regulus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Regulus Therapeutics: Rigel Pharmaceuticals, Inc. (2.73%), XOMA Co. (0.96%), Vanda Pharmaceuticals Inc. (5.60%), Verastem, Inc. (5.11%), Lexicon Pharmaceuticals, Inc. (12.80%), Achieve Life Sciences, Inc. (8.32%), Agenus Inc. (12.34%), Fortress Biotech, Inc. (12.86%), SAB Biotherapeutics, Inc. (1.32%), Curis, Inc. (0.99%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Regulus Therapeutics stock?

Short selling RGLS is an investing strategy that aims to generate trading profit from Regulus Therapeutics as its price is falling. RGLS shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regulus Therapeutics?

A short squeeze for Regulus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RGLS, which in turn drives the price of the stock up even further.

How often is Regulus Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGLS, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:RGLS) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners